van Velzen, Laura S.
Kelly, Sinead
Isaev, Dmitry
Aleman, Andre
Aftanas, Lyubomir I.
Bauer, Jochen
Baune, Bernhard T. http://orcid.org/0000-0001-6548-426X
Brak, Ivan V. http://orcid.org/0000-0002-5146-0096
Carballedo, Angela
Connolly, Colm G. http://orcid.org/0000-0002-4051-3682
Couvy-Duchesne, Baptiste
Cullen, Kathryn R.
Danilenko, Konstantin V.
Dannlowski, Udo
Enneking, Verena
Filimonova, Elena
Förster, Katharina
Frodl, Thomas
Gotlib, Ian H.
Groenewold, Nynke A.
Grotegerd, Dominik
Harris, Mathew A. http://orcid.org/0000-0002-1135-4141
Hatton, Sean N.
Hawkins, Emma L.
Hickie, Ian B.
Ho, Tiffany C.
Jansen, Andreas
Kircher, Tilo
Klimes-Dougan, Bonnie
Kochunov, Peter
Krug, Axel
Lagopoulos, Jim
Lee, Renick
Lett, Tristram A. http://orcid.org/0000-0002-0731-9626
Li, Meng
MacMaster, Frank P.
Martin, Nicholas G. http://orcid.org/0000-0003-4069-8020
McIntosh, Andrew M. http://orcid.org/0000-0002-0198-4588
McLellan, Quinn http://orcid.org/0000-0003-3806-2218
Meinert, Susanne
Nenadić, Igor
Osipov, Evgeny
Penninx, Brenda W. J. H.
Portella, Maria J.
Repple, Jonathan
Roos, Annerine
Sacchet, Matthew D.
Sämann, Philipp G.
Schnell, Knut
Shen, Xueyi
Sim, Kang
Stein, Dan J. http://orcid.org/0000-0001-7218-7810
van Tol, Marie-Jose http://orcid.org/0000-0002-9260-5490
Tomyshev, Alexander S.
Tozzi, Leonardo
Veer, Ilya M.
Vermeiren, Robert
Vives-Gilabert, Yolanda
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Walter, Martin
van der Wee, Nic J. A.
van der Werff, Steven J. A.
Schreiner, Melinda Westlund http://orcid.org/0000-0002-2780-3327
Whalley, Heather C. http://orcid.org/0000-0002-4505-8869
Wright, Margaret J. http://orcid.org/0000-0001-7133-4970
Yang, Tony T.
Zhu, Alyssa
Veltman, Dick J.
Thompson, Paul M.
Jahanshad, Neda http://orcid.org/0000-0003-4401-8950
Schmaal, Lianne
Article History
Received: 23 August 2018
Revised: 15 April 2019
Accepted: 10 May 2019
First Online: 30 August 2019
Compliance with ethical standards
:
: IBH has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects. He was a member of the Medical Advisory Panel for Medibank Private, a Board Member of Psychosis Australia Trust and a member of Veterans Mental Health Clinical Reference group. He is the Chief Scientific Advisor to, and an equity shareholder in, Innowell. AMM has received research support from Janssen, Eli Lilly and The Sackler Trust. AMM has also received speaker's fees from Illumina and Janssen. The remaining authors declare that they have no conflict of interest.